LVAD-Induced Reverse Remodeling: Basic and Clinical Implications for Myocardial Recovery

Journal of Cardiac Failure

Volumn 12, Issue 3, 2006, Pages 227-239

  Burkhoff, Daniel ^a,b,c   Klotz, Stefan ^d   Mancini, Donna M ^c  

^a CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b IMPULSE Dynamics   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

excitation contraction coupling; extracellular matrix; Heart failure; hypertrophy; right ventricle

Indexed keywords

BIOMECHANICS; CARDIAC PATIENT; CONVALESCENCE; EXTRACELLULAR MATRIX; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART VENTRICLE CONTRACTILITY; HEART WORK; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

HEART; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MYOCARDIAL CONTRACTION; TIME FACTORS; VENTRICULAR REMODELING;

EID: 33646057720     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2005.10.012     Document Type: Review

References (141)

1. Deng M.C., Edwards L.B., Hertz M.I., Rowe A.W., Keck B.M., Kormos R., et al. Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: second annual report-2004. J Heart Lung Transplant 23 (2004) 1027-1034
2. Levin H.R., Oz M., Catanese K., Rose E.A., and Burkhoff D. Transient normalization of systolic and diastolic function after LVAD support in a patient with dilated cardiomyopathy. J Heart Lung Transplant 15 (1996) 840-842
3. Mancini D.M., Beniaminovitz A., Levin H., Catanese K., Flannery M., DiTullio M., et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98 (1998) 2383-2389
4. Frazier O.H., Benedict C.R., Radovancevic B., Bick R.J., Capek P., Springer W.E., et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 62 (1996) 675-681
5. Farrar D.J., Holman W.R., McBride L.R., Kormos R.L., Icenogle T.B., Hendry P.J., et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 21 (2002) 516-521
6. Mann D.L., and Willerson J.T. Left ventricular assist devices and the failing heart: a bridge to recovery, a permanent assist device, or a bridge too far?. Circulation 98 (1998) 2367-2369
7. Loebe M., Hennig E., Muller J., Spiegelsberger S., Weng Y., and Hetzer R. Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement. Eur J Cardiothorac Surg 11 Suppl (1997) S18-S24
8. Muller J., Wallukat G., Weng Y.G., Dandel M., Spiegelsberger S., Semrau S., et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 96 (1997) 542-549
9. Mancini D., and Burkhoff D. Mechanical device-based methods of managing and treating heart failure. Circulation 112 (2005) 438-448
10. Wohlschlaeger J., Schmitz K.J., Schmid C., Schmid K.W., Keul P., Takeda A., et al. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Cardiovasc Res 68 (2005) 376-386
11. Razeghi P., Myers T.J., Frazier O.H., and Taegtmeyer H. Reverse remodeling of the failing human heart with mechanical unloading. Emerging concepts and unanswered questions. Cardiology 98 (2002) 167-174
12. Burkhoff D., Holmes J.W., Madigan J., Barbone A., and Oz M.C. Left ventricular assist device-induced reverse ventricular remodeling. Prog Cardiovasc Dis 43 (2000) 19-26
13. Heerdt P.M., and Burkhoff D. Reverse molecular remodeling of the failing human heart following support with a left ventricular assist device. In: Dhalla N.S. (Ed). Signal transduction and cardiac hypertrophy (2002), Kluwer Academic Publishers, Boston 19-35
14. Margulies K.B. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J Card Fail 8 (2002) S500-S505
15. Klotz S., and Burkhoff D. Cardiac assist devices: effects on reverse remodeling. In: Kohl P., Sachs F., and Franz M.R. (Eds). Cardiac mechano-electric feedback and arrhythmias: from pipette to patient (2005), Saunders, Philadelphia 342-353
16. Levin H.R., Oz M.C., Chen J.M., Packer M., Rose E.A., and Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 91 (1995) 2717-2720
17. Baldwin R.T., Duncan J.M., Radovancevic B., Frazier O.H., and Abou-Awdi N.L. Recovery of pulmonary function in patients undergoing extended left ventricular assistance. Chest 102 (1992) 45-49
18. Barbone A., Holmes J.W., Heerdt P.M., The' A.H., Naka Y., Joshi N., et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation 104 (2001) 670-675
19. Klotz S., Barbone A., Reiken S., Holmes J.W., Naka Y., Oz M.C., et al. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol 45 (2005) 668-676
20. Klotz S., Foronjy R.F., Dickstein M.L., Gu A., Garrelds I.M., Danser A.H., et al. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation 112 (2005) 364-374
21. Kavarana M.N., Pessin-Minsley M.S., Urtecho J., Catanese K.A., Flannery M., Oz M.C., et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 73 (2002) 745-750
22. Ochiai Y., McCarthy P.M., Smedira N.G., Banbury M.K., Navia J.L., Feng J., et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 106 (2002) I198-I202
23. Klotz S., Deng M.C., Stypmann J., Roetker J., Wilhelm M.J., Hammel D., et al. Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. Ann Thorac Surg 77 (2004) 143-149
24. James K.B., McCarthy P.M., Jaalouk S., Bravo E.L., Betkowski A., Thomas J.D., et al. Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices. Circulation 93 (1996) 1515-1519
25. Ferrari M., Kadipasaoglu K.A., Croitoru M., Conger J., Myers T., Gregoric I., et al. Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant 24 (2005) 226-228
26. McCarthy P.M., Savage R.M., Fraser C.D., Vargo R., James K.B., Goormastic M., et al. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device. J Thorac Cardiovasc Surg 109 (1995) 409-417
27. Madigan J.D., Barbone A., Choudhri A.F., Morales D.L.S., Cai B., Oz M.C., et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg 121 (2001) 902-908
28. Barbone A., Oz M.C., Burkhoff D., and Holmes J.W. Normalized diastolic properties after left ventricular assist result from reverse remodeling of chamber geometry. Circulation 104 (2001) I229-I232
29. Altemose G.T., Gritsus V., Jeevanandam V., Goldman B., and Margulies K.B. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant 16 (1997) 765-773
30. Zafeiridis A., Jeevanandam V., Houser S.R., and Margulies K.B. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98 (1998) 656-662
31. Moazami N., Argenziano M., Kohmoto T., Yazdani S., Rose E.A., Burkhoff D., et al. Inflow valve regurgitation during LVAD support may interfere with reverse ventricular remodeling. Ann Thorac Surg 65 (1998) 628-631
32. McCarthy P.M., Nakatani S., Vargo R., Kottke-Marchant K., Harasaki H., et al. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 59 (1995) 609-613
33. Holman W.L., Bourge R.C., Fan P., Kirklin J.K., Pacifico A.D., and Nanda N.C. Influence of longer term left ventricular assist device support on valvular regurgitation. ASAIO J 40 (1994) M454-M459
34. Nakatani S., McCarthy P.M., Kottke-Marchant K., Harasaki H., James K.B., Savage R.M., et al. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol 27 (1996) 894-901
35. Baba H.A., Grabellus F., August C., Plenz G., Takeda A., Tjan T.D., et al. Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support. J Heart Lung Transplant 19 (2000) 668-674
36. Bruckner B.A., Stetson S.J., Perez-Verdia A., Youker K.A., Radovancevic B., Connelly J.H., et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 20 (2001) 457-464
37. Flesch M., Margulies K.B., Mochmann H.C., Engel D., Sivasubramanian N., and Mann D.L. Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading. Circulation 104 (2001) 2273-2276
38. de Jonge N., van Wichen D.F., Schipper M.E., Lahpor J.R., Gmelig-Meyling F.H., Robles de Medina E.O., et al. Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments. J Am Coll Cardiol 39 (2002) 963-969
39. Terracciano C.M., Harding S.E., Adamson D., Koban M., Tansley P., Birks E.J., Barton P.J., et al. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur Heart J 24 (2003) 1329-1339
40. Khan T., Delgado R.M., Radovancevic B., Torre-Amione G., Abrams J., Miller K., et al. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant 22 (2003) 137-146
41. Thohan V., Stetson S.J., Nagueh S.F., Rivas-Gotz C., Koerner M.M., Lafuente J.A., et al. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant 24 (2005) 566-575
42. Dipla K., Mattiello J.A., Jeevanandam V., Houser S.R., and Margulies K.B. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 97 (1998) 2316-2322
43. Heerdt P.M., Holmes J.W., Cai B., Barbone A., Madigan J.D., Reiken S., et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102 (2000) 2713-2719
44. Ogletree-Hughes M.L., Stull L.B., Sweet W.E., Smedira N.G., McCarthy P.M., and Moravec C.S. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 104 (2001) 881-886
45. Chaudhary K.W., Rossman E.I., Piacentino III V., Kenessey A., Weber C., Gaughan J.P., et al. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart. J Am Coll Cardiol 44 (2004) 837-845
46. Terracciano C.M., Hardy J., Birks E.J., Khaghani A., Banner N.R., and Yacoub M.H. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 109 (2004) 2263-2265
47. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
48. Chen X., Piacentino III V., Furukawa S., Goldman B., Margulies K.B., and Houser S.R. L-type Ca2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices. Circ Res 91 (2002) 517-524
49. Bick R.J., Grigore A.M., Poindexter B.J., Schnee P.M., Nussmeier N.A., Gregoric I.D., et al. Left ventricular unloading with an assist device results in receptor relocalization as well as increased beta-adrenergic receptor numbers: are these changes indications for outcome?. J Card Surg 20 (2005) 332-336
50. Grigore A., Poindexter B., Vaughn W.K., Nussmeier N., Frazier O.H., Cooper J.R., et al. Alterations in alpha adrenoreceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device. J Heart Lung Transplant 24 (2005) 609-613
51. Uray I.P., Connelly J.H., Frazier O.H., Taegtmeyer H., and Davies P.J. Mechanical unloading increases caveolin expression in the failing human heart. Cardiovasc Res 59 (2003) 57-66
52. James K.B., McCarthy P.M., Thomas J.D., Vargo R., Hobbs R.E., Sapp S., et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation 92 (1995) II191-II195
53. Delgado III R., Radovancevic B., Massin E.K., Frazier O.H., and Benedict C. Neurohormonal changes after implantation of a left ventricular assist system. ASAIO J 44 (1998) 299-302
54. Milting H., El Banayosy A., Kassner A., Fey O., Sarnowski P., Arusoglu L., et al. The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types. J Heart Lung Transplant 20 (2001) 949-955
55. Uray I.P., Connelly J.H., Thomazy V., Shipley G.L., Vaughn W.K., Frazier O.H., et al. Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart. J Heart Lung Transplant 21 (2002) 771-782
56. Razeghi P., Young M.E., Ying J., Depre C., Uray I.P., Kolesar J., et al. Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology 97 (2002) 203-209
57. Kuhn M., Voss M., Mitko D., Stypmann J., Schmid C., Kawaguchi N., et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc Res 64 (2004) 308-314
58. Thompson L.O., Skrabal C.A., Loebe M., Lafuente J.A., Roberts R.R., Akgul A., et al. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients. J Surg Res 123 (2005) 25-32
59. Birks E.J., Felkin L.E., Banner N.R., Khaghani A., Barton P.J., and Yacoub M.H. Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices. J Heart Lung Transplant 23 (2004) 228-235
60. Birks E.J., Latif N., Owen V., Bowles C., Felkin L.E., Mullen A.J., et al. Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices. Circulation 104 (2001) I233-I240
61. Corry D.C., DeLucia III A., Zhu H., Radcliffe R.R., Brevetti G.R., El Khatib H., et al. Time course of cytokine release and complement activation after implantation of the HeartMate left ventricular assist device. ASAIO J 44 (1998) M347-M351
62. Kanda T., and Takahashi T. Interleukin-6 and cardiovascular diseases. Jpn Heart J 45 (2004) 183-193
63. Torre-Amione G., Stetson S.J., Youker K.A., Durand J.B., Radovancevic B., Delgado R.M., et al. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 100 (1999) 1189-1193
64. Razeghi P., Mukhopadhyay M., Myers T.J., Williams J.N., Moravec C.S., Frazier O.H., et al. Myocardial tumor necrosis factor-alpha expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support. Ann Thorac Surg 72 (2001) 2044-2050
65. Kucuker S.A., Stetson S.J., Becker K.A., Akgul A., Loebe M., Lafuente J.A., et al. Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy. J Heart Lung Transplant 23 (2004) 28-35
66. Loebe M., Koster A., Sanger S., Potapov E.V., Kuppe H., Noon G.P., et al. Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device. ASAIO J 47 (2001) 272-274
67. Stetson S.J., Perez-Verdia A., Vatta M., Bowles N.E., Towbin J.A., and Torre-Amione G. Improved myocardial structure following LVAD support: effect of unloading on dystrophin expression. J Heart Lung Transplant 20 (2001) 240
68. Vatta M., Stetson S.J., Perez-Verdia A., Entman M.L., Noon G.P., Torre-Amione G., et al. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet 359 (2002) 936-941
69. Vatta M., Stetson S.J., Jimenez S., Entman M.L., Noon G.P., Bowles N.E., et al. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J Am Coll Cardiol 43 (2004) 811-817
70. Noguchi T., Hunlich M., Camp P.C., Begin K.J., El Zaru M., Patten R., et al. Thin-filament-based modulation of contractile performance in human heart failure. Circulation 110 (2004) 982-987
71. Aquila L.A., McCarthy P.M., Smedira N.G., Young J.B., and Moravec C.S. Cytoskeletal structure and recovery in single human cardiac myocytes. J Heart Lung Transplant 23 (2004) 954-963
72. Birks E.J., Hall J.L., Barton P.J., Grindle S., Latif N., Hardy J.P., et al. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation 112 (2005) I57-I64
73. Li Y.Y., Feng Y., McTiernan C.F., Pei W., Moravec C.S., Wang P., et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation 104 (2001) 1147-1152
74. Bruckner B.A., Stetson S.J., Farmer J.A., Radovancevic B., Frazier O.H., Noon G.P., et al. The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. Am J Surg 180 (2000) 498-501
75. Barton P.J., Birks E.J., Felkin L.E., Cullen M.E., Koban M.U., and Yacoub M.H. Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure. J Heart Lung Transplant 22 (2003) 738-744
76. Skrabal C.A., Thompson L.O., Southard R.E., Joyce D.L., Noon G.P., Loebe M., et al. Interaction between isolated human myocardial mast cells and cultured fibroblasts. J Surg Res 118 (2004) 66-70
77. Akgul A., Skrabal C.A., Thompson L.O., Loebe M., Lafuente J.A., Noon G.P., et al. Role of mast cells and their mediators in failing myocardium under mechanical ventricular support. J Heart Lung Transplant 23 (2004) 709-715
78. Lee S.H., Doliba N., Osbakken M., Oz M., and Mancini D. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. J Thorac Cardiovasc Surg 116 (1998) 344-349
79. Mital S., Loke K.E., Addonizio L.J., Oz M.C., and Hintze T.H. Left ventricular assist device implantation augments nitric oxide dependent control of mitochondrial respiration in failing human hearts. J Am Coll Cardiol 36 (2000) 1897-1902
80. Park S.J., Zhang J., Ye Y., Ormaza S., Liang P., Bank A.J., et al. Myocardial creatine kinase expression after left ventricular assist device support. J Am Coll Cardiol 39 (2002) 1773-1779
81. Grabellus F., Schmid C., Levkau B., Breukelmann D., Halloran P.F., August C., et al. Reduction of hypoxia-inducible heme oxygenase-1 in the myocardium after left ventricular mechanical support. J Pathol 197 (2002) 230-237
82. Goldstein A.H., Monreal G., Kambara A., Spiwak A.J., Schlossberg M.L., Abrishamchian A.R., et al. Partial support with a centrifugal left ventricular assist device reduces myocardial oxygen consumption in chronic, ischemic heart failure. J Card Fail 11 (2005) 142-151
83. Heerdt P.M., Schlame M., Jehle R., Barbone A., Burkhoff D., and Blanck T.J. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann Thorac Surg 73 (2002) 1216-1221
84. Francis G.S., Anwar F., Bank A.J., Kubo S.H., and Jessurun J. Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: observations made after implantation of left ventricular assist device. J Card Fail 5 (1999) 308-315
85. Narula J., Arbustini E., Chandrashekhar Y., and Schwaiger M. Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes. Cardiol Clin 19 (2001) 113-126
86. Haider N., Narula N., and Narula J. Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling. J Card Fail 8 (2002) S512-S517
87. Baba H.A., Stypmann J., Grabellus F., Kirchhof P., Sokoll A., Schafers M., et al. Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism. Cardiovasc Res 59 (2003) 390-399
88. de Jonge N., van Wichen D.F., van Kuik J., Kirkels H., Lahpor J.R., Gmelig-Meyling F.H., et al. Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators. J Heart Lung Transplant 22 (2003) 1028-1036
89. Patten R.D., Denofrio D., El Zaru M., Kakkar R., Saunders J., Celestin F., et al. Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart. J Am Coll Cardiol 45 (2005) 1419-1424
90. Ankersmit H.J., Edwards N.M., Schuster M., John R., Kocher A., Rose E.A., et al. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation 100 (1999) II211-II215
91. Ankersmit H.J., Tugulea S., Spanier T., Weinberg A.D., Artrip J.H., Burke E.M., et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 354 (1999) 550-555
92. Uray I.P., Connelly J.H., Frazier O., Taegtmeyer H., and Davies P.J. Altered expression of tyrosine kinase receptors Her2/neu and GP130 following left ventricular assist device (LVAD) placement in patients with heart failure. J Heart Lung Transplant 20 (2001) 210
93. Razeghi P., Bruckner B.A., Sharma S., Youker K.A., Frazier O.H., and Taegtmeyer H. Mechanical unloading of the failing human heart fails to activate the protein kinase B/Akt/glycogen synthase kinase-3beta survival pathway. Cardiology 100 (2003) 17-22
94. Huebert R.C., Li Q., Adhikari N., Charles N.J., Han X., Ezzat M.K., et al. Identification and regulation of Sprouty1, a negative inhibitor of the ERK cascade, in the human heart. Physiol Genomics 18 (2004) 284-289
95. Grabellus F., Levkau B., Sokoll A., Welp H., Schmid C., Deng M.C., et al. Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support. Cardiovasc Res 53 (2002) 124-130
96. Barton P.J., Felkin L.E., Birks E.J., Cullen M.E., Banner N.R., Grindle S., et al. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy. Circulation 112 (2005) I46-I50
97. Harding J.D., Piacentino III V., Gaughan J.P., Houser S.R., and Margulies K.B. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 104 (2001) 1241-1247
98. Harding J.D., Piacentino V., Rothman S., Chambers S., Jessup M., and Margulies K.B. Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure. J Card Fail 11 (2005) 227-232
99. Tansley P., Yacoub M., Rimoldi O., Birks E., Hardy J., Hipkin M., et al. Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy. J Heart Lung Transplant 23 (2004) 1283-1289
100. Tsutsui T., Takiya R., Jikuya T., Shigeta O., Sakakibara Y., and Sankai Y. Effect of left ventricular assist device on circulatory autonomic nervous activity. Int J Artif Organs 27 (2004) 243-250
101. Margulies K.B., Matiwala S., Cornejo C., Olsen H., Craven W.A., and Bednarik D. Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res 96 (2005) 592-599
102. Rodrigue-Way A., Burkhoff D., Geesaman B.J., Golden S., Xu J., Pollman M.J., et al. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transplant 24 (2005) 73-80
103. Blaxall B.C., Tschannen-Moran B.M., Milano C.A., and Koch W.J. Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 41 (2003) 1096-1106
104. Hall J.L., Grindle S., Han X., Fermin D., Park S., Chen Y., et al. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics 17 (2004) 283-291
105. Helman D.N., Maybaum S.W., Morales D.L., Williams M.R., Beniaminovitz A., Edwards N.M., et al. Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable?. Ann Thorac Surg 70 (2000) 1255-1258
106. El Banayosy A., Arusoglu L., Kizner L., Fey O., Sarnowski P., Morshuis M., et al. Hemodynamic exercise testing reveals a low incidence of myocardial recovery in LVAD patients. J Heart Lung Transplant 20 (2001) 209-210
107. Dandal M, Weng Y, Sinawski H, PE, Hetzer R. Long-term outcome in patients with idiopathic dilated cardiomyopathy after weaning from LVAD. J Heart Lung Transplant 2005;25:S107.
108. Hon J.K., and Yacoub M.H. Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg 75 (2003) S36-S41
109. Maybaum S., Frazier O.H., Starling R.C., Miller L.W., Murali S., Aaronson K.D., et al. Low rate of cardiac recovery despite cellular recovery during LVAD support: results from the LVAD working group. J Am Coll Cardiol 41 (2005) 165A
110. Matsumiya G., Monta O., Fukushima N., Sawa Y., Funatsu T., Toda K., et al. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?. J Thorac Cardiovasc Surg 130 (2005) 699-704
111. Holman W.L., Bourge R.C., and Kirklin J.K. Case report: circulatory support for seventy days with resolution of acute heart failure. J Thorac Cardiovasc Surg 102 (1991) 932-934
112. Hoy F.B., Mueller D.K., Geiss D.M., Munns J.R., Bond L.M., Linett C.E., et al. Bridge to recovery for postcardiotomy failure: is there still a role for centrifugal pumps?. Ann Thorac Surg 70 (2000) 1259-1263
113. Rockman H.A., Adamson R.M., Dembitsky W.P., Bonar J.W., and Jaski B.E. Acute fulminant myocarditis: long-term follow-up after circulatory support with left ventricular assist device. Am Heart J 121 (1991) 922-926
114. Jett G.K., Miller A., Savino D., and Gonwa T. Reversal of acute fulminant lymphocytic myocarditis with combined technology of OKT3 monoclonal antibody and mechanical circulatory support. J Heart Lung Transplant 11 (1992) 733-738
115. Yacoub M.H. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 22 (2001) 534-540
116. Yacoub M.H., Birks E.J., Tansley P., and Bowles C. Bride to recovery: the Harefield approach. J Congest Hart Fail Circul Suppl 2 (2001) 27-30
117. Burkhoff D., Mirsky I., and Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 289 (2005) H501-H512
118. Pfeffer J.M., Fischer T.A., and Pfeffer M.A. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol 57 (1995) 805-826
119. Burkhoff D., Flaherty J.T., Yue D.T., Herskowitz A., Oikawa R.Y., Sugiura S., et al. In vitro studies of isolated supported human hearts. Heart Vessels 4 (1988) 185-196
120. McKay R.G., Miller M.J., Ferguson J.J., Momomura S.I., Sahagian P., and Grossman W. Assessment of left ventricular end-systolic pressure-volume relations with an impedance catheter and transient inferior vena cava occlusion: use of this system in the evaluation of cardiotonic effects of dobutamine, milrinone, posicor and epinephrine. J Am Col Cardiol 8 (1986) 1152-1160
121. Greenberg B., Quinones M.A., Koilpillai C., Limacher M., Shindler D., Benedict C., et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 91 (1995) 2573-2581
122. Frazier O.H. First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation 89 (1994) 2908-2914
123. Klotz S., Naka Y., Oz M.C., and Burkhoff D. Biventricular assist device-induced right ventricular reverse structural and functional remodeling. J Heart Lung Transplant 24 (2005) 1195-1201
124. Parker T.G., and Schneider M.D. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype. Annu Rev Physiol 53 (1991) 179-200
125. Liu Y., and Kitsis R.N. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J Cell Biol 133 (1996) 325-334
126. Anversa P. Myocyte apoptosis and heart failure. Eur Heart J 19 (1998) 359-360
127. Potapov E.V., Loebe M., Abdul-Khaliq H., Koster A., Stein J., Sodian R., et al. Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs. J Heart Lung Transplant 20 (2001) 1310-1316
128. Klotz S., and Schmid C. Arterial pressure and pump flow rate during long-term pulsatile and nonpulsatile cardiac support: reply. Ann Thorac Surg 79 (2005) 1094
129. Kherani A.R., Maybaum S., and Oz M.C. Ventricular assist devices as a bridge to transplant or recovery. Cardiology 101 (2004) 93-103
130. Hetzer R., Muller J., Weng Y., Wallukat G., Spiegelsberger S., and Loebe M. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg 68 (1999) 742-749
131. Soppa G.K., Smolenski R.T., Latif N., Yuen A.H., Malik A., Karbowska J., et al. Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle. Am J Physiol Heart Circ Physiol 288 (2005) H1468-H1476
132. Wong K., Boheler K.R., Bishop J., Petrou M., and Yacoub M.H. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. Cardiovasc Res 37 (1998) 115-122
133. Wong K., Boheler K.R., Petrou M., and Yacoub M.H. Pharmacological modulation of pressure-overload cardiac hypertrophy: changes in ventricular function, extracellular matrix, and gene expression. Circulation 96 (1997) 2239-2246
134. Barton P.J.R., Bhavsar P.K., Felkin L.E., Sugden P.H., and Yacoub M.H. Morphological and molecular effects of clenbuterol on cardiac myocytes: role of IGF-1. J Heart Lung Transplant 23 (2004) S53-S54
135. Towbin J.A., and Bowles N.E. The failing heart. Nature 415 (2002) 227-233
136. Komuro I., and Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 55 (1993) 55-75
137. Hunter J.J., and Chien K.R. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341 (1999) 1276-1283
138. Dib N., McCarthy P., Campbell A., Yeager M., Pagani F.D., Wright S., et al. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant 14 (2005) 11-19
139. Pagani F.D., DerSimonian H., Zawadzka A., Wetzel K., Edge A.S., Jacoby D.B., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41 (2003) 879-888
140. Chaudhry P.A., Mishima T., Sharov V.G., Hawkins J., Alferness C.A., Paone G., et al. Passive epicardial containment prevents ventricular remodeling in heart failure. Ann Thorac Surg 70 (2000) 1275-1280
141. The Heart Simulator. Available from online at: http://www.columbia.edu/itc/hs/medical/heartsim/. Accessed December 14, 2005.